These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32024621)

  • 1. Alpha-glucosidase inhibition and molecular docking studies of 1,2-benzothiazine 1,1-dioxide based carbohydrazides.
    Saddique FA; Ahmad M; Ashfaq UA; Ahmad MN; Anjum MN; Mohsin NA; Aslam S
    Pak J Pharm Sci; 2019 Nov; 32(6(Supplementary)):2829-2834. PubMed ID: 32024621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and α-Glucosidase Inhibition Activity of 2-[3-(Benzoyl/4-bromobenzoyl)-4-hydroxy-1,1-dioxido-2
    Saddique FA; Aslam S; Ahmad M; Ashfaq UA; Muddassar M; Sultan S; Taj S; Hussain M; Sung Lee D; Zaki MEA
    Molecules; 2021 May; 26(10):. PubMed ID: 34065194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-silico modeling and in-vitro studies of 2,1-benzothiazine-2,2-dioxide based hydrazone derivatives as α-glucosidase inhibitors.
    Ahmad S; Taj S; Aslam S; Gul Khan S; Farooq T; Ashfaq UA; Ahmad M
    Pak J Pharm Sci; 2021 Sep; 34(5(Supplementary)):1951-1955. PubMed ID: 34836865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring of novel 4-hydroxy-2H-benzo[e][1,2]thiazine-3-carbohydrazide 1,1-dioxide derivative as a dual inhibitor of α-glucosidase and α-amylase: Molecular docking, biochemical, enzyme kinetic and in-vivo mouse model study.
    Taj S; Ahmad M; Ashfaq UA
    Int J Biol Macromol; 2022 May; 207():507-521. PubMed ID: 35276296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Diabetic Activity of 2,3,6-Tribromo-4,5-Dihydroxybenzyl Derivatives from
    Paudel P; Seong SH; Park HJ; Jung HA; Choi JS
    Mar Drugs; 2019 Mar; 17(3):. PubMed ID: 30875760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morning glory resin glycosides as α-glucosidase inhibitors: In vitro and in silico analysis.
    Rosas-Ramírez D; Escandón-Rivera S; Pereda-Miranda R
    Phytochemistry; 2018 Apr; 148():39-47. PubMed ID: 29421509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of α-glucosidase.
    Rahim F; Ullah H; Javid MT; Wadood A; Taha M; Ashraf M; Shaukat A; Junaid M; Hussain S; Rehman W; Mehmood R; Sajid M; Khan MN; Khan KM
    Bioorg Chem; 2015 Oct; 62():15-21. PubMed ID: 26162519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Docking of Isolated Alkaloids for Possible α-Glucosidase Inhibition.
    Rahman N; Muhammad I; ; Khan H; Aschner M; Filosa R; Daglia M
    Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31569830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Mercapto Benzothiazole Derivatives: As Potential Leads for the Diabetic Management.
    Ullah S; Mirza S; Salar U; Hussain S; Javaid K; Khan KM; Khalil R; Atia-Tul-Wahab ; Ul-Haq Z; Perveen S; Choudhary MI
    Med Chem; 2020; 16(6):826-840. PubMed ID: 31195949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro α-Glucosidase Inhibition by Non-sugar based Triazoles of Dibenzoazepine, their Structure-Activity Relationship, and Molecular Docking.
    Khan MA; Javaid K; Wadood A; Jamal A; Batool F; Fazal-Ur-Rehman S; Basha FZ; Choudhary MI
    Med Chem; 2017; 13(7):698-704. PubMed ID: 28745232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
    Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
    Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giganteone A and malabaricone C as potential pharmacotherapy for diabetes mellitus.
    Sivasothy Y; Leong KH; Loo KY; Adbul Wahab SM; Othman MA; Awang K
    Nat Prod Res; 2022 Mar; 36(6):1581-1586. PubMed ID: 33593208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coumarin linked thiazole derivatives as potential α-glucosidase inhibitors to treat diabetes mellitus.
    Ichale R; Kanhed AM; Vora A
    Mol Divers; 2024 Jun; 28(3):1239-1247. PubMed ID: 37118160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
    Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
    Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.
    Ye GJ; Lan T; Huang ZX; Cheng XN; Cai CY; Ding SM; Xie ML; Wang B
    Eur J Med Chem; 2019 Sep; 177():362-373. PubMed ID: 31158750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
    Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B
    Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic investigation of anthocyanidin derivatives as α-glucosidase inhibitors.
    Kim JH; Kim HY; Jin CH
    Bioorg Chem; 2019 Jun; 87():803-809. PubMed ID: 30978605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
    Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
    Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li X; Li J
    Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.